Acute ischemic heart disease is associated with alterations in the cardiac adenylate cyclase system response, although the specificity and mechanism of these events are unknown. We studied the characteristics of inhibitory (G,) and stimulatory (G s ) GTP-binding regulatory proteins (G proteins) of adenylate cyclase in erythrocyte membranes of patients (n=16) with nonacute ischemic heart disease resulting from coronary atherosclerosis. G s was measured by reconstitution with the resolved catalytic unit of adenylate cyclase and by cholera toxin-catalyzed ADP-ribosylation of a 42 -kD protein; G, was tested as a 41-kD substrate of pertussis toxin-catalyzed ADP-ribosylation. G s activity was decreased by 27 ±2% in the cholate extract and by 25±3% in the supernatant of guanosine 5'-(y-thio)triphosphate-treated membranes. The amount of cholera toxin substrate was decreased by 33 ±3%, and the pertussis toxin substrate was increased by 27±5% compared with healthy subjects (n=10). All changes in G-protein characteristics appear to be specific relative to other erythrocyte membrane proteins and hemoglobin. Those patients who have a decreased G s possess approximately normal G,, and those with increased G, showed no change in G s . Patients with increased G, (normal G s ) exhibited more severe deterioration of their coronary arteries than did patients with decreased G s (normal Gj) (P<.05), but these two groups did not differ significantly in serum lipids, hormones, drug therapy, historical data, or baseline assessment their appropriate effector(s) via mechanisms that are mediated by distinct GTP-binding regulatory proteins (G proteins; reviewed in Reference 1). The sensitivity of adenylate cyclase, including the catalytic component and receptors that typify a signal transmission system, to stimulatory and inhibitory hormones is regulated by G proteins. G proteins are heterotrimers formed of a, )3, and y subunits. The a subunits bind and hydrolyze GTP, undergo ADP-ribosylation by bacterial toxins, and define the receptor and effector specificity of G proteins. The a subunits are proposed to be the primary messengers of hormone action because of their ability to dissociate from membranes on activation 2 by guanine nucleotides 3 and hormone-receptor complexes. 4 Stimulatory G s and inhibitory G, regulatory proteins couple receptors on stimulation or inhibition, respectively, of adenylate cy-
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any receptors have been shown to stimulate their appropriate effector(s) via mechanisms that are mediated by distinct GTP-binding regulatory proteins (G proteins; reviewed in Reference 1). The sensitivity of adenylate cyclase, including the catalytic component and receptors that typify a signal transmission system, to stimulatory and inhibitory hormones is regulated by G proteins. G proteins are heterotrimers formed of a, )3, and y subunits. The a subunits bind and hydrolyze GTP, undergo ADP-ribosylation by bacterial toxins, and define the receptor and effector specificity of G proteins. The a subunits are proposed to be the primary messengers of hormone action because of their ability to dissociate from membranes on activation 2 by guanine nucleotides 3 and hormone-receptor complexes. 4 Stimulatory G s and inhibitory G, regulatory proteins couple receptors on stimulation or inhibition, respectively, of adenylate cy-clase. G s stimulates the Ca 2+ channel, and G s a is ADP-ribosylated by cholera toxin. G, regulates adenylate cyclase and Ca 2+ channels, stimulates K + channels, and is involved in phosphoinositide metabolism; G,a is ADP-ribosylated by pertussis toxin. 4 There is evidence that in addition to /3-adrenoceptor downregulation, 5 organ-specific alterations in G-protein function contribute to the pathophysiology of human heart disease. 6 Moreover, /3-adrenoceptor defects may indeed be postreceptor defects. 7 The exact mechanism of G-protein alteration is still questionable because of discrepancies between different studies that may be due to inadequate experimental technique or insufficient numbers of patients (n<5). 6 Ischemic heart disease is most commonly due to obstruction of the coronary arteries, which in turn usually results from arteriosclerosis. In experimental acute myocardial ischemia, hormone-stimulated cAMP production in the heart is reduced. 8 - 9 There is evidence that regulation of the adenylate cyclase system is altered, so that the response of cells to adrenergic signaling is decreased. 10 This may be a result of the abnormal coupling of /3-adrenoceptors to G proteins."
The aim of the present study was to measure the functional activity of G s and to quantify the substrates of cholera and pertussis toxin-catalyzed ADP-ribosyla-tion, which represent, with some limitations, the amounts of G s and Gj, respectively, in erythrocyte membranes of patients with nonacute ischemic heart disease resulting from coronary atherosclerosis. Because samples of heart tissue are not available from patients with the nonacute stage of disease because no heart transplantation or other surgical interventions are required, the only way to determine G-protein characteristics is by the study of blood cells. We selected erythrocytes for the reasons listed below. First, human erythrocyte membranes are easily available, so a large enough group of patients may be investigated. Second, the membrane preparation is pure and contains only plasma membranes. Third, human erythrocytes lack adrenergic receptors as well as functional adenylate cyclase activity, 12 which are both lost during reticulocyte maturation, 13 so that the effect of catecholamines on the steady-state levels of G proteins does not occur. Fourth, the methods of determination of G-protein activity and level in erythrocyte membranes are well denned, and they are even used as a standard. Fifth, we selected patients without severe biochemical abnormalities with the exception of coronary artery disease and avoided including patients with acute ischemia; this enabled us to determine the alterations in G-protein characteristics that occur before the onset of serious metabolic disorders, 14 since all patients were in the initial stages of the pathological process.
Methods

Patients
The study comprised 16 male patients with ischemic heart disease aged 35 to 58 years (mean, 47 years). All subjects were under treatment at the Research Center for Preventive Medicine and gave written permission to participate in the study. Fourteen patients had angina pectoris functional class I through III, and 2 had chest pain syndrome due to neurocirculatory asthenia. Eight patients had concomitant essential mild hypertension; plasma cholesterol levels did not exceed 260 mg/dL (mean±SEM, 238±12 mg/dL), which indicates the absence of significant hypercholesterolemia in the Moscow population. 15 Patients with diabetes mellitus, thyroid disease, and previous myocardial infarction were withdrawn from the study. To verify the presence of coronary atherosclerosis and with the aim of choosing further drug therapy, coronary bypass surgery, or percutaneous transluminal coronary angioplasty, all patients had recently undergone coronary arteriography 16 under intracoronary injection of nitroglycerin (200 /xg per each artery) and demonstrated significant (more than 50%) narrowing of at least one coronary artery. Films were recorded using Cardaskop-U angiography apparatus (Siemens) equipped with a K-30 video camera. The image was translated to the Matrix Videotron-LFP/640 system (Matrix Computer AG), which combines the Matrix VME data and the Leutron digital image-processing system. Artery segments (eight to 12) were manually outlined three times each using original software, and the mean diameter value was used for further calculations. Interobserver and intraobserver variations were 3% and 7%, respectively. Global coronary atherosclerosis score (GCS), an index showing the severity of coronary atherosclerosis, was estimated by two observers independently as follows. First, the percent stenosis (%S) was calculated according to the equation where D mm , D prox , and D dis , are minimal, proximal, and distal diameters of arteries, respectively. Second, the degree of stenosis (DS) was estimated: DS was assumed to be 0 when no occlusion was detected; 1, if %S ranged from 1% to 25%; 2, if %S ranged from 26% to 50%; 3, if %S was 51% to 70%; 4, if %S was 71% to 90%; 5, if %S was 91% to 99%; and 6, for complete occlusion. Localization of stenosis (LS) was assumed to be 1 for all arteries after ramification; 2, for the distal; 3, for the middle; and 4, for the proximal part of arteries. GCS was calculated according to the equation The control group comprised 10 healthy subjects (male, aged 27 to 46 years; mean, 38 years) without complaints. All volunteers had normal blood pressure and serum cholesterol levels (less than 220 mg/dL; mean±SEM, 186±8 mg/dL) and showed no abnormalities on the electrocardiogram.
Preparation of Erythrocyte Membranes
A venous blood sample was withdrawn by a standard Vacutainer at 8 AM after a 14-hour fast. EDTA was used as an anticoagulant. Erythrocytes were isolated using the Ficoll-Paque method as described by the instructions of the manufacturer (Pharmacia). Cells were removed from the bottom of the tubes and the hemoglobin content per 10 12 cells was determined. No contamination with lymphocytes was observed. Two milliliters of erythrocytes was washed three times in 10 mL of an isotonic solution containing 5 mmol/L sodium phosphate, pH 7.8, and 140 mmol/L NaCl. Membranes were prepared by the method of Dodge et al 17 with modifications. 18 The final membrane preparation (10 mg of protein per milliliter) was divided into small aliquots, frozen in liquid nitrogen, and stored at -70°f or 2 months. Such storage conditions did not result in any detectable loss of G s activity or pertussis and cholera toxin-catalyzed ADP-ribosylation, as determined in a separate experiment. The preparation and storage procedures were standardized for all samples to avoid any possible differences. On the day of the experiment, membranes were thawed and washed twice 
Assay of G s Activity
G s activity was measured by reconstitution with the resolved catalytic unit of adenylate cyclase in phospholipid vesicles. The catalytic unit of adenylate cyclase was partially purified from bovine brain caudate nuclei and resolved from G s by the method of Neer and Salter, 19 and reconstitution was performed as described previously. 3 G s activity was assayed in two ways: (1) For "total" G s , erythrocyte membranes were resuspended in an initial volume of TED buffer containing 1% sodium cholate and 600 mmol/L NaCl, stirred for 1 hour at 4°C, and centrifuged at 100 OOOg for 1 hour. The supernatant containing G s was diluted with 3 volumes of TED buffer; guanosine 5'-(y-thio)triphosphate (GTPyS) and MgCl 2 were added to make their final concentrations 0.1 mmol/L and 10 mmol/L, respectively. Samples were incubated for 1 hour at 30°C and thus, activated cholate extract was immediately reconstituted with the adenylate cyclase preparation. (2) For "soluble" G s , we have previously shown that human erythrocyte G s dissociates specifically from membranes in the presence of nonhydrolyzable GTP analogues. ]cAMP produced was estimated as described. 21 All samples were assayed simultaneously on the same day using the same preparation of catalytic unit in duplicate, and the experiments were repeated three times. The background activity (boiled, G s -containing fractions or those reconstituted in the absence of GTPyS and MgCl 2 gave the same results) was subtracted from the obtained value, and G s activity was expressed in picomoles of cAMP produced per minute per milligram of either initial cholate extract ("total" G s ) or total membrane protein ("soluble" G s ). The assays were linear for the indicated amount of protein and the indicated incubation time. Because of the relatively high interassay variation (7±4%), three different experiments were analyzed independently. Results were expressed as the percent activity of patient samples vs the G s activity of healthy donor samples (assumed to be 100%).
Cholera and Pertussis Toxin-Catalyzed [ 32 P]ADP-Ribosylation
Erythrocyte membranes were resuspended in half of the initial volume and subjected to ADP ribosylation. for 30 minutes at 30°C), 10 /xg of guanylyl-5'-imidodiphosphate-treated human erythrocyte cytosol, and 10 /xL of membrane protein (0.2 to 0.9 mg/mL). We followed the recommendations of Rosenthal et al 22 and added NADP to inhibit endogenous NADase; NADase activity of the membrane preparation was undetectable under these assay conditions. Incubation was carried out for 1 hour at 30°C. The reaction was stopped by addition of 15 /xL of a denaturation mixture and boiling of the samples for 3 minutes. Boiled samples were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). We avoided centrifugation of the samples before solubilization because the a subunit of G s is released from the membrane after cholera toxin-catalyzed ADP-ribosylation, 23 thus decreasing and underestimating the observed extent of ADP-ribosylation.
The incubation mixture for pertussis toxin labeling in the final volume of 40 /iL contained 50 mmol/L Tris- The addition of lubrol PX was necessary because in the absence of detergent, pertussis toxin ADP-ribosylates only 5% to 10% of the total G,. 24 Incubation was carried out for 1 hour at 37°C and the reaction was stopped by addition of 15 /xL of a denaturation mixture and boiling for 3 minutes. Boiled samples were analyzed by SDS-PAGE. G o protein, purified from bovine brain, served as a reference standard. 25 Addition of /3y subunits had no effect (n=4, P<.05) on pertussis toxin-catalyzed modification under our experimental conditions.
In general, all samples were assayed simultaneously in duplicate and the experiments were repeated three times with the same results. Both assays were linear within the protein concentrations indicated. The correlation coefficients calculated for three different membrane preparations as described below were 0.96±0.07 for the cholera toxin-catalyzed reaction and 0.98±0.08 for the pertussis toxin-catalyzed reaction. The extent of both toxin-catalyzed ADP-ribosylation reactions reached a stable (up to 1.5 hours) plateau after 45 minutes of incubation as determined in a separate experiment. The addition of fresh toxins after 45 minutes of incubation had no effect on label incorporation.
In the case of cholera toxin the labeling of a 42-kD protein (G s a) was estimated, and in the case of pertussis toxin the labeling of a 41-kD protein (G,al plus G,o2) was measured (Figure) . Human erythrocyte membranes possess only one form of G s a 12 and three forms of G, (G.la, 41 kD; G,2a, 41 kD; and GJa, 43 kD). 26 The ADP-ribosylation of Gj3a is low and does not correlate with the amount of protein in membranes. 
41-
ADP-ribosylation results were expressed in arbitrary units and
SDS-PAGE and Quantification of Results
Polyacrylamide gels (10%, 1 mm thick) were run in the system of Laemmli 28 in the presence of 0.1% SDS at a constant current of 25 mA for 1.5 hours at room temperature. Gels were fixed for 30 minutes in 25% 2-propanol and 10% acetic acid; stained for 30 minutes in 50% ethanol, 10% acetic acid, and 0.5% Coomassie Brilliant Blue R-250; destained for 10 minutes in boiling water; dried for 45 minutes; and autoradiographed for 22 and 44 hours in an intensifying screen cassette with Amersham Hyperfilm MP (preflashed). A typical example of the ADP-ribosylation assays is presented in the Figure. Both films (22 and 44 hours) were scanned with an Ultroscan XL laser densitometer (LKB) three times for each lane. The densitometer was linked to an Olivetti M-290 personal computer and the peak areas were estimated using GELSCAN XL software (version 2.0). The average value for each lane was calculated. The linearity of peak area vs degree of labeling was verified in a separate experiment. The amount of protein applied was verified by direct measurement of the membrane protein and also by scanning the protein lanes on the dried gel three times. The use of higher concentrations of [ 32 P]NAD (10 /xmol/L) in the presence of 1 mmol/L NADP allowed us to accurately and semiquantitatively estimate the true amounts of toxin substrates. Despite the time-consuming procedures of gel and autoradiogram scanning, the calculation protocol provided by GELSCAN XL software allows precise determination of peak areas (SEM was less than 1%). The data for each polypeptide as a percentage of total membrane protein area were estimated. 32 P]ATP as described. 30 Cholera toxin, the molecular weight determination kit, lubrol PX, ATP, cAMP, and thymidine were from Sigma Chemical Co, St Louis, Mo. Sodium cholate, EDTA, DTT, creatine phosphate, and creatine kinase were from Serva, Heidelberg, FRG. Reagents for electrophoresis were supplied by Bio-Rad. All nucleotides were from Boehringer Mannheim. Pertussis toxin was from Calbiochem. All other reagents were of analytical grade.
The serum concentrations of hormones were determined with the following commercial kits. Radioimmunoassay (RIA) kits for determination of luteinizing, adrenocorticotropic, follicle-stimulating, and thyroidstimulating hormones and prolactin were supplied by CIS Intern Co. RIA kits for determination of cortisol, insulin, triiodthyronine, thyroxine, and thyroxine-binding globulin were from the Institute of Bioorganic Chemistry, Minsk, Byelorussia. The growth hormone assay kit was from the Institute of Experimental Endocrinology, Kaunas, Lithuania, and RIA kits for determination of testosterone, progesterone, and estradiol were from the Institute of Experimental Medicine, Sukhumi, Georgia. Catecholamines were determined by using the high-performance liquid chromatography assay kit obtained from Dia-M Co, Moscow, Russia. All hormones were assayed according to the manufacturers' instructions. Testosterone-binding globulin and cortisol-binding globulin were measured as described. 31 Serum lipids were assayed according to Gerasimova et al. 32 Protein content was determined by the method of Lowry et al 33 with bovine serum albumin as the standard.
The data shown are mean ± SEM. Statistical significance was estimated with a nonparametric rank test. A value of P<.05 was considered significant.
Results
The characteristics of G proteins were compared in erythrocyte membranes from patients with ischemic heart disease and from those of healthy subjects. Significant alterations in both G s activities were detected: the one in cholate extract (holo G s ; a and /3y subunits) and the other in GTPy S-soluble form (G s a subunit only) were decreased by 27% and 25%, respectively ( Table 1) . The decrease in the G s a subunit was confirmed by measurement after cholera toxin-catalyzed ADP-ribosylation. A 33% decrease in cholera toxin substrate was observed. In contrast, the amount of pertussis toxin substrate, representing the G,a subunit, was increased by 27% (Table 1) . These changes appear to be specific because no other erythrocyte protein relative-mass fractions were altered. Table 2 contains a list of the five major protein bands. This was also true for up to 17 minor protein bands. These data together with the hemoglobin measurements (4.9±0.2 g/10 12 cells in healthy donor samples and 4.9±0.3 g/10 12 cells in patient samples) indicate that erythrocytes from both healthy donors and patients were indistinguishable in their hemoglobin content and membrane composition.
To elucidate the possible mechanism of G-protein alterations, we analyzed the G-protein characteristics of each patient individually. Individual analysis revealed a very high correlation between "total" G s , "soluble" G s , and the amount of cholera toxin substrate (r=0.92±0.06, / 5 <.01), thus enabling us to combine these characteristics as one G s . Moreover, the patients were observed to have either an increased G, or a decreased G s , ie, these events did not occur simultaneously. This fact allowed us to split the initial group of patients into two smaller groups and to analyze them independently. One group contained patients with an increased G; but a normal level and activity of G s , and the other group had a decreased G s but normal or The amount of protein was estimated as described in "Methods" by laser densitometry.
tBands were named according to Fairbanks et al. 34 All values were not significantly different as determined by the rank test. insignificantly increased (by means of exclusion Q criteria, / ) <.O5) G, (Table 3 ). It is evident that such differences, although they would result in the alteration of adenylate cyclase in both groups, may be due to either increased inhibition of adenylate cyclase activity (group 2, with increased G,) or decreased stimulation of adenylate cyclase (group 1, with decreased G s ).
This finding suggests a marked difference between these two groups, but we were not able to detect them on the basis of other factors. These groups were not significantly different with respect to lipid levels (Table  3) , hemoglobin content, plasma concentrations of various hormones (Table 4) , drug therapy, historical data, and baseline clinical assessment ( Table 5 ). The only difference detected was that in GCS, an index showing the status of coronary atherosclerosis. The patients who exhibited more severe atherosclerosis (GCS of 15.0±1.8) represent the group with an increased G i; and those with milder forms of coronary artery disease (GCS of 8.4 ±1.2) represent the group with a decreased G s . When the correlation between GCS and G proteins was investigated, these findings became evident, since there was a positive correlation between GCS and G ( ADP-ribosylation and a negative one between GCS and G s characteristics, although they were not strong enough to be significant (+0.83±0.12 and -0.7±0.18, respectively; P<A). The correlation between G proteins and the other tested parameters listed in Tables 3, 4 , and 5 was significantly lower, with means ranging from -0.44 to 0.57 (data not presented). The same was true when nonlinear (exponential, logarithmic, and hyperbolic) correlations were determined.
Discussion
The determination of G-protein characteristics in erythrocyte membranes is a well-defined procedure, so human erythrocyte membranes are often used as a standard. We have slightly updated the methods for determination of G s activity by reconstitution with the resolved catalytic unit of adenylate cyclase (SEM was typically 2% to 4%) and for estimation of pertussis (SEM was 4% to 6%) and cholera (SEM did not exceed 10%) toxin substrates. This allowed us to observe alterations in G s activity and the quantity of toxin substrates in patients with ischemic heart disease and healthy subjects (Table 1) . These alterations appeared to be specific, because the mass fractions of other membrane proteins appeared to be unchanged (Table   TABLE 5 2). This is an additional advantage of the experimental design used in the present study because even after short periods of myocardial infarction or during severe heart failure, very significant alterations in heart muscle tissue may occur, thus affecting quantification of the G proteins and adenylate cyclase activity. 35 G-protein alterations in general are a result of the processes listed below. A decrease in G, and an increase in G s in the steady-state levels of endogenously ADPribosylated proteins may affect the extent of ADPribosylation by cholera and pertussis toxins. Endogenous ADP-ribosyltransferases present in erythrocytes may substantially lower the degree of cholera 36 as well as pertussis 37 toxin-catalyzed labeling, but they would not affect the reconstitution activity of G s , thus confirming the decrease in cholera toxin substrate. The increase in pertussis toxin substrate cannot be explained by an increase in endogenous cysteine-specific ADP-ribosylation or phosphorylation of G;a, 38 since these events are able to only lower the apparent amount of pertussis toxin substrate. Changes in other membrane proteins and enzymes are able to influence the observed value of ADP-ribosylation. The latter possibility seems not to be true, because the addition of /3y subunits purified from bovine brain did not stimulate ADP-ribosylation of G; by pertussis or of G s by cholera toxin. Moreover, the guanylyl-5'-imidodiphosphate-treated erythrocyte cytosol used as a source for ADP-ribosylating factor for cholera toxin-catalyzed ADP-ribosylation 39 was added in excess, so the ADP-ribosylating factor did not affect the cholera toxin-catalyzed reaction. More likely is that a change in the amount of protein (G s a and G,2a+Gjla) occurred.
The question about the mechanism of such alterations has several answers in general. First, the amount of G proteins may be changed during the reticulocyte stage of maturation under the influence of hormones acting through the cAMP 40 - 41 or other receptor-dependent 42 pathways. Second, differential or impaired selective degradation of G proteins may occur in erythrocytes. 43 Third, the proportion of soluble or cytoplasmic G proteins is possibly subject to change, 44 but we observed no decrease in the guanine nucleotide-dependent dissociation of G s ("soluble" G s ) relative to the amount of "total" G s .
To determine whether G proteins are changed in response to hormonal stimulus or any physiological changes, we determined the correlations between G proteins and a number of parameters of lipid levels, oxygen consumption, hormone metabolism, and drug therapy and found no significant correlations. This may be due to the insufficient number of patients investigated. Nevertheless, only one of the tested parameters, GCS, correlated with G-protein characteristics. Then we used the individual approach and noticed that patients have either an increased G, or a decreased G s but not both of these simultaneously. This fact allowed us to split the patients into two groups as characterized in Tables 3, 4 , and 5. No difference between these groups was found with one exception: a significant difference in GCS was observed.
G-protein alterations are likely to be ubiquitous in cardiovascular disease. They occur in the heart, muscle, lymphocytes and, as shown in the present study, erythrocytes. Thus, the tissue specificity of G-protein alter-ations as postulated by Feldman 6 becomes questionable. Functional defects in G s a and da may contribute to the different abnormalities in cardiovascular pathology. The data of the present study apparently contrast with the findings of Bohm et al, 45 who did not detect G, alterations in heart membranes of patients with ischemic cardiomyopathy. However, these authors did not estimate the lesions of coronary arteries in their group of patients; additionally, our patients did not exhibit heart failure (Table 5) . Thus, one cannot extrapolate from the results of Bohm et al to G-protein characteristics in ischemic heart disease or moreover to erythrocyte membrane G proteins.
We speculate that G-protein levels are altered independently of functional adenylate cyclase (ie, cAMP), plasma lipids, hormones, drug therapy, and a number of physiological parameters but are correlated with coronary atherosclerosis lesion status. No function for either G s or G, can be definitively stated for human red blood cells because of their lack of functional adenylate cyclase activity and j3-adrenergic receptors, although they may interact with other receptors, effector enzymes, 1 and Na + ,K + -ATPase. 46 Recently, Buhler et al 47 suggested that low-density lipoprotein and high-density lipoprotein regulate the interactions of many cell types, acting through their receptors in a manner similar to other hormones, and that these receptors may be coupled to G proteins. Hence, G-protein level alterations are able to change cellular responses to lipoprotein effects and thus contribute to atherogenesis.
